CPH2, the UK-based green hydrogen technology and manufacturing group that has developed the IP-protected Membrane-Free Electrolyser ("MFE"), today announced the admission of its entire issued ordinary share capital to trading on AIM, a market operated by the London Stock Exchange.

Admission follows an over-subscribed Placing by Cenkos Securities for a total of 67,717,818 Ordinary Shares at 45p per Ordinary Share (the "Placing Price"), raising gross proceeds of £30.5m (before expenses).

Jon Duffy, Chief Executive Officer of CPH2, said:
"Today's listing and over-subscribed placing, delivered in difficult stock market conditions, is an important milestone for CPH2 and will assist the rapid growth of the Group. The funds raised will further strengthen the Group's financial position and will enable CPH2 to build out our Doncaster manufacturing operation. CPH2 has an opportunity to penetrate an extremely fast-growing hydrogen market and aims to become a globally recognised, highly profitable designer, manufacturer and licensor of its MFE technology, targeting 4GW production capacity by 2030, an opportunity further advanced by the move onto the public markets.

"The Group is now in a position to continue significant investment into its research and development capacity and enhance our intellectual property position whilst establishing a stock of completed units to deliver the substantial and continually growing opportunity pipeline.

"I am delighted we have been awarded the London Stock Exchange's Green Economy Mark at Admission, which recognises companies that derive 50% or more of their total annual revenues from products and services that contribute to the global green economy.

"I am grateful for all the hard work of our team, and I would like to thank our new and existing shareholders for their support. We are confident in our ability deliver on the opportunities ahead and I look forward to providing updates on our progress as our business develops."